The FDA has approved long-awaited changes to the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) to minimize the burden on patients, prescribers, and pharmacies while protecting safe use of the ...

After up to three years on GA Depot, most people with PPMS have not experienced any disability progression, according to new ...

The investigational oral therapy KTX-1001, also known as gintemetostat, is catching interest as a potential treatment for a subgroup of patients with multiple myeloma, as an expert explained in a ...

Many popular apps collect far more personal data than they need to work. These 20 apps quietly gather your photos, location, contacts, and more—and you probably have at least one of them installed ...